Legend Biotech (LEGN) has released an update.
Legend Biotech Corporation has enhanced its leadership by appointing former Yale University President Peter Salovey to its Board of Directors as an independent director. Dr. Salovey’s extensive background in medical research, public health, and academic leadership is expected to offer valuable insights and contribute to the company’s strategic growth in the cell therapy sector. His involvement underscores the company’s commitment to innovation in treatments for life-threatening diseases.
For further insights into LEGN stock, check out TipRanks’ Stock Analysis page.
